This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Saga University, Kurume University, Shino-Test Corporation. Active years: 2016-2017.
Company Filing History:



Years Active: 2016-2017
Title: Kazuhiko Arima: Innovator in Medical Diagnostics
Introduction
Kazuhiko Arima is a notable inventor based in Saga, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the detection of chronic sinusitis and related conditions. With a total of 2 patents, his work has the potential to improve patient outcomes through more accurate and less invasive testing methods.
Latest Patents
Arima's latest patents include a method for diagnosing chronic sinusitis. This invention provides a way to detect chronic sinusitis by measuring the concentration of a periostin protein in blood or nasal secretion collected from a test subject. The method is designed to be simpler, more prompt, and less invasive than traditional diagnostic techniques. Another significant patent involves an antibody capable of binding to a specific region of periostin, along with a method for measuring periostin using this antibody. This invention aims to enhance the accuracy of periostin measurement and offers a method for testing pulmonary fibrosis or interstitial pneumonia with improved precision.
Career Highlights
Kazuhiko Arima has worked with prominent institutions such as Saga University and Shino-Test Corporation. His experience in these organizations has allowed him to develop innovative solutions that address critical health issues.
Collaborations
Arima has collaborated with notable colleagues, including Kenji Izuhara and Shoichiro Ohta. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Kazuhiko Arima's contributions to medical diagnostics exemplify the impact of innovation in healthcare. His patents not only enhance diagnostic accuracy but also pave the way for improved patient care.